Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Genentech
Genentech
Genentech insists it hasn't lost its R&D mojo
Fierce Biotech
Mon, 11/30/09 - 11:08 am
R&D
Genentech
Roche
Genentech, Biogen Idec get FDA request on application for Rituxan's use in leukemia
Yahoo/AP
Thu, 11/19/09 - 07:52 am
Genentech
Roche
Biogen Idec
FDA
Rituxan
leukemia
Roche applies for Avastin advanced breast cancer use
Reuters
Tue, 11/17/09 - 10:59 am
Avastin
Roche
breast cancer
Genentech
What Genentech and Roche Got From Congress for $15M
BNET Pharma
Sun, 11/15/09 - 06:18 pm
Roche
congress
Genentech
healthcare reform
No Product Revenues, Plenty of Risk: Buy Exelixis?
CNBC
Mon, 11/9/09 - 09:59 am
Exelixis
GSK
Bristol-Myers Squibb
Sanofi
Roche
Genentech
Medicare gives eye docs their way on Avastin
Fierce Pharma
Wed, 10/28/09 - 02:33 pm
Avastin
Medicare
Lucentis
macular degeneration
Genentech
Brain Disease Found in 3rd Patient on Roche’s Rituxan
Bloomberg
Mon, 10/26/09 - 09:41 am
Roche
Genentech
arthritis
Rituxan
Genentech brand to replace Roche in U.S.
Fierce Pharma
Mon, 10/19/09 - 06:41 pm
Genentech
Roche
Genentech and Biogen Idec Receive a Complete Response from FDA for Earlier Use of Rituxan for Rheumatoid Arthritis
Businesswire
Mon, 10/19/09 - 07:46 am
Rituxan
rheumatoid arthritis
Roche
Genentech
FDA
Phase III Study Showed Two Years of ACTEMRA® (tocilizumab) Inhibited Progression of Joint Damage and Improved Disease Remission
Reuters
Sun, 10/18/09 - 10:58 am
Actemra
tocilizumab
rheumatoid arthritis
Genentech
Senator probes Medicare shift to Lucentis
Fierce Pharma
Wed, 10/14/09 - 10:50 am
Medicare
Lucentis
Avastin
Genentech
Roche To Give Genentech Employees More Options
Pharmalot
Tue, 10/13/09 - 10:22 am
Roche
Genentech
M&A
The inside scoop on Roche's integration of Genentech
Fierce Pharma
Thu, 10/8/09 - 08:35 am
Roche
Genentech
restructuring
M&A
Lucentis improves sight after 7 days in 2 studies
Reuters
Mon, 10/5/09 - 10:49 am
Lucentis
Genentech
RVO
retinal vein occlusion
Roche
Rituxan tests positive in Phase III trial
Fierce Pharma
Thu, 09/17/09 - 11:12 am
Rituxan
Genentech
lymphoma
Roche taps new pharma head after Genentech buy
Reuters
Tue, 09/8/09 - 07:42 am
Roche
Genentech
M&A
Roche Drug Shrinks Tumors in Study
WSJ Online
Wed, 09/2/09 - 06:55 pm
Roche
skin cancer
Genentech
Data backs Avastin as second-line treatment
Fierce Pharma
Tue, 08/18/09 - 11:23 am
Roche
Avastin
breast cancer
Genentech
Roche Raises Targets on Genentech Acquisition Savings
Bloomberg
Thu, 07/23/09 - 07:31 am
Roche
Genentech
M&A
OSIP gets boost from Tarceva tests
NASDAQ.com
Mon, 07/13/09 - 09:48 am
OSI Pharmaceuticals
Tarceva
lung cancer
Roche
Genentech
Pages
« first
‹ previous
…
16
17
18
19
20
21
22
23
24
…
next ›
last »